Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.23750/abm.v91i3.10366 http://scihub22266oqcxt.onion/10.23750/abm.v91i3.10366 32921727!7716973!32921727     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Acta+Biomed 2020 ; 91 (3): e2020033 Nephropedia Template TP {{tp|p=32921727|t=2020. COVID-19 and Type 1 Diabetes: Concerns and Challenges |pdf=|usr=}}{{32921727}} gab.com Text COVID-19 and Type 1 Diabetes: Concerns and Challenges JO: Acta Biomed http://www.kidney.de/pget.php?&tw=1&pmid=32921727 #FOAvip Due to the current COVID-19 pandemic, worldwide population's lifestyle has changed dramatically, causing psychosocial consequences. Patients presenting a preexisting chronic condition, as Type 1 Diabetes (T1D), are the ones suffering the most from this situation. Moreover, people affected by diabetes are the ones with the worst prognosis, if infected by SARS-CoV-2. We analyzed why patients with T1D were poorly represented between the subjects hospitalized for COVID-19 and why the cases of diabetic ketoacidosis (DKA) were fewer and more severe compared with the past years. Furthermore, literature has showed how patients of all ages with T1D did not experience a deterioration in their glucose control throughout the lockdown. Among other causes, this is also due to the surging use of telemedicine. Finally, we tried to understand how the coronavirus tropism for endocrine tissues could influence the future epidemiology of T1D, focusing on the effects they have on pancreatic beta-cells. Twit Text FOAVip COVID-19 and Type 1 Diabetes: Concerns and Challenges ????Acta Biomed http://www.kidney.de/pget.php?&tw=1&pmid=32921727 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32921727 #FOAvip English Wikipedia <ref>{{Cite pmid|32921727}}</ref> COVID-19 and Type 1 Diabetes: Concerns and Challenges #MMPMID32921727 Iughetti L; Trevisani V; Cattini U; Bruzzi P; Lucaccioni L; Madeo S; Predieri B Acta Biomed 2020[Sep]; 91 (3): e2020033 PMID32921727show ga Due to the current COVID-19 pandemic, worldwide population's lifestyle has changed dramatically, causing psychosocial consequences. Patients presenting a preexisting chronic condition, as Type 1 Diabetes (T1D), are the ones suffering the most from this situation. Moreover, people affected by diabetes are the ones with the worst prognosis, if infected by SARS-CoV-2. We analyzed why patients with T1D were poorly represented between the subjects hospitalized for COVID-19 and why the cases of diabetic ketoacidosis (DKA) were fewer and more severe compared with the past years. Furthermore, literature has showed how patients of all ages with T1D did not experience a deterioration in their glucose control throughout the lockdown. Among other causes, this is also due to the surging use of telemedicine. Finally, we tried to understand how the coronavirus tropism for endocrine tissues could influence the future epidemiology of T1D, focusing on the effects they have on pancreatic beta-cells. |*Betacoronavirus[MESH] |*Pandemics[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology[MESH] |Diabetes Mellitus, Type 1/*epidemiology[MESH] |Global Health[MESH] |Humans[MESH] |Pneumonia, Viral/*epidemiology[MESH] |Prevalence[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]COVID-19 and Type 1 Diabetes: Concerns and Challenges (epmc).pdf DeepDyve Pubget Overpricing